文献速递乳腺病理细胞病理与分子病理

二代测序在乳腺病理中的应用:十年真实实践影响

Next-generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction.
PubMed 文献 · Histopathology · 2023-01-01

本文综述二代测序(NGS)引入乳腺病理十年来的实际影响。NGS用于检测BRCA1/2、PIK3CA等靶向治疗相关突变,并辅助未知原发淋巴结转移癌诊断、乳腺梭形细胞肿瘤鉴别及原发与复发相关性判断。NGS使病理医生能将形态学分析与分子改变结合应用于疑难诊断。

要点

  • NGS可检测BRCA1/2、PIK3CA等靶向治疗相关突变。
  • NGS辅助未知原发淋巴结转移癌的诊断分型。
  • NGS有助鉴别乳腺梭形细胞肿瘤及判断原发复发关系。

核心结论

  • NGS是强大的工具,使病理医生在疑难诊断中能将形态学分析与分子改变结合。

研究设计与样本

  • 综述,总结NGS引入乳腺病理十年来的实际应用经验。

主要发现

  • NGS可评估BRCA1/2或PIK3CA突变,这些是新获批疗法的靶点。
  • NGS可辅助未知原发淋巴结转移癌的诊断检查。
  • NGS可辅助鉴别乳腺梭形细胞肿瘤为化生性癌、恶性叶状肿瘤或肉瘤。
  • NGS可辅助判断原发乳腺癌与复发灶之间的相关性。

临床怎么用

  • 在疑难诊断场景中,病理医生可将形态学分析与NGS分子改变结合使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The diagnosis, histomolecular classes of breast cancers (luminal A, luminal B, HER2-enriched, and basal-like), and accurate prediction of prognosis are commonly determined using morphological and phenotypical analyses in clinical practice worldwide. Therapeutic strategies are mostly based on the disease stage and molecular subclasses of breast cancer. Targeted therapies, such as anti-HER2s, poly-ADP ribose polymerase inhibitors or, to a lesser extent, phosphatidylinositol 3 kinase inhibitors, have substantially improved breast cancer patient prognosis over the past decades. Human epidermal growth factor receptor 2 (HER2) overexpression is widely determined based on immunohistochemistry, while next-generation sequencing (NGS) is currently employed to assess the presence of molecular alterations, including breast cancer gene 1 (BRCA1) and 2 or phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations, which are targets of these new approved therapies. In addition, next-generation sequencing (NGS) can aid the pathologist in challenging situations, such as a diagnostic workup for a metastatic carcinoma in lymph nodes of unknown origin, differential diagnosis of spindle cell tumourtumor in the breast between metaplastic carcinoma, malignant PT and sarcoma, o, as well as determining relatedness between primary breast cancers and recurrences. NGS offers a powerful tool that enables the pathologist to combine morphological analyses together with molecular alterations in challenging diagnostic situations.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Nourieh M, Vibert R, Saint-Ghislain M, et al. Next-generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction. Histopathology. 2023. PMID: 36482269. doi:10.1111/his.14794

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。